학술논문
15 - Efficacy and Safety of Once-Weekly Semaglutide vs. Sitagliptin as Add-on to Metformin and/or Thiazolidinediones after 56 Weeks in Subjects with Type 2 Diabetes (SUSTAIN 2)
Document Type
Abstract
Author
Source
In Canadian Journal of Diabetes October 2016 40(5) Supplement:S6-S6
Subject
Language
ISSN
1499-2671